Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
61,855.06 +2,793.51 (+4.73%) CMC Crypto 200
1,339.85 +62.87 (+4.92%)
Sana Biotechnology, Inc. (SANA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:39PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.16B |
| Enterprise value | 2.06B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 7.53 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -7.68 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.61 |
| 52-week change 3 | 71.58% |
| S&P500 52-week change 3 | 22.43% |
| 52-week high 3 | 12.00 |
| 52-week low 3 | 2.74 |
| 50-day moving average 3 | 9.12 |
| 200-day moving average 3 | 5.86 |
Share statistics
| Avg vol (3-month) 3 | 2.06M |
| Avg vol (10-day) 3 | 1.9M |
| Shares outstanding 5 | 221.32M |
| Implied shares outstanding 6 | 221.32M |
| Float 8 | 129M |
| % held by insiders 1 | 9.06% |
| % held by institutions 1 | 84.68% |
| Shares short (15 Apr 2024) 4 | 26.72M |
| Short ratio (15 Apr 2024) 4 | 19.99 |
| Short % of float (15 Apr 2024) 4 | 25.20% |
| Short % of shares outstanding (15 Apr 2024) 4 | 12.07% |
| Shares short (prior month 15 Mar 2024) 4 | 24.68M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -29.44% |
| Return on equity (ttm) | -72.00% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -302.34M |
| Net income avi to common (ttm) | -283.26M |
| Diluted EPS (ttm) | -1.46 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 205.2M |
| Total cash per share (mrq) | 0.93 |
| Total debt (mrq) | 104.1M |
| Total debt/equity (mrq) | 36.21% |
| Current ratio (mrq) | 3.31 |
| Book value per share (mrq) | 1.45 |
Cash flow statement
| Operating cash flow (ttm) | -253.58M |
| Levered free cash flow (ttm) | -199.92M |
© 2024 Yahoo. All rights reserved.